Evidence map›Paper›PMID 29868577›Full record

ReviewFrontiers in bioengineering and biotechnology2018

An Effective Translation: The Development of Hyaluronan-Based Medical Products From the Physicochemical, and Preclinical Aspects.

Gloria Huerta-Ángeles, Kristina Nešporová, Gabriela Ambrožová, Lukas Kubala, Vladimir Velebný

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Materials today. Bio · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gloria Huerta-ÁngelesDepartment of Research and Development, Contipro a.s., Dolní Dobrouč, Czechia.
Kristina NešporováDepartment of Research and Development, Contipro a.s., Dolní Dobrouč, Czechia.
Gabriela AmbrožováFree Radical Pathophysiology, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia.
Lukas KubalaFree Radical Pathophysiology, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia.
Vladimir VelebnýDepartment of Research and Development, Contipro a.s., Dolní Dobrouč, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review shows the steps toward material selection focalized on the design and development of medical devices based on hyaluronan (HA). The selection is based on chemical and mechanical properties, biocompatibility, sterilization, safety, and scale-up costs. These facts play a vital role in the industrialization process. Approved medical devices containing-HA are illustrated to identify key parameters. The first part of this work involves the steps toward a complete characterization of chemical and mechanical aspects, reproducibility of the processes and scale up. In a second stage, we aimed to describe the preclinical

Indexed as

chemical modificationclinical datacross-linkedFDAhyaluronanhydrogelpreclinical datarisk management

Identifiers

PMID29868577
PMCPMC5966713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.